J&J Covid vaccine recipients are higher off getting Pfizer or Moderna booster, NIH examine suggests

0
137

[ad_1]

Pfizer-BioNTech Covid-19 vaccines at a senior residing facility in Worcester, Pennsylvania, U.S., on Wednesday, Aug. 25, 2021.

Hannah Beier | Bloomberg | Getty Photographs

Johnson & Johnson Covid-19 vaccine recipients are higher off getting a booster shot from Pfizer or Moderna, a extremely anticipated U.S. examine recommended Wednesday.

The examine on “mixing and matching” Covid vaccines included greater than 450 adults who’ve obtained one of many three regimens at present accessible in the USA: J&J’s, Moderna’s or Pfizer’s. The examine hasn’t but been peer-reviewed.

This can be a creating story. Please examine again for updates.

[ad_2]

Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here